Cargando…
Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study
BACKGROUND: Recent studies have highlighted the possible risk of neuropsychiatric adverse effects during treatment with lipid-lowering medications. However, there are still controversies that require a novel genetic-based approach to verify whether the impact of lipid-lowering drug treatment results...
Autores principales: | Alghamdi, Jahad, Matou-Nasri, Sabine, Alghamdi, Faisal, Alghamdi, Saleh, Alfadhel, Majid, Padmanabhan, Sandosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276028/ https://www.ncbi.nlm.nih.gov/pubmed/29986042 http://dx.doi.org/10.1093/ijnp/pyy060 |
Ejemplares similares
-
Stimulatory effects of Lycium shawii on human melanocyte proliferation, migration, and melanogenesis: In vitro and in silico studies
por: Alghamdi, Khalid, et al.
Publicado: (2023) -
Determination of benchmark doses for linear furanocoumarin consumption associated with inhibition of cytochrome P450 1A2 isoenzyme activity in healthy human adults
por: Alehaideb, Zeyad, et al.
Publicado: (2021) -
Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia
por: Alsultan, Abdullah, et al.
Publicado: (2020) -
Establishing plausibility of cardiovascular adverse effects of immunotherapies using Mendelian randomisation
por: Le, Nhu Ngoc, et al.
Publicado: (2023) -
The Potential Association Between Periodontal Diseases and Adverse Pregnancy Outcomes in Pregnant Women: A Systematic Review of Randomized Clinical Trials
por: Alnasser, Bashayer H, et al.
Publicado: (2023)